Joe.My.God. LGBT News
NBC News reports:
A Food and Drug Administration advisory panel voted Tuesday to recommend Merck’s experimental antiviral pill to treat Covid-19 for emergency use authorization, paving the way for the agency to clear the first oral drug for the disease.
Members of the agency’s Antimicrobial Drugs Advisory Committee voted 13-10 in favor of the treatment, called molnupiravir, for use in adults with mild to moderate Covid-19 who are at risk for severe disease or hospitalization.
The FDA is not required to follow the advisory committee’s guidance, but it usually does. The nation is currently averaging 5,456 Covid hospitalizations and 1,032 deaths per day, according to the Centers for Disease Control and Prevention.
Read the full article.
Breaking News: An expert panel recommended that the FDA authorize Merck’s Covid pill for high-risk adults, which the agency could do within days. https://t.co/S80r4EyaZs
— The New York Times (@nytimes) November 30, 2021
Close vote 13-10#molnupiravir gets its EUA recommendation.
It may reduce risk of hospital admission by 30%.
A new drug with some benefit is good news however
vaccination is still your best protection against #COVID19https://t.co/nmtSe7RwKl— BK Titanji #ILookLikeAScientist (@Boghuma) November 30, 2021